Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5750)
All Articles published online
|
Publishing Process of This Article
|
Oct 26, 2020 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Palmer J, Leeuwenkamp OR. Cost-effectiveness of lutetium (177Lu) oxodotreotide vs everolimus in gastroenteropancreatic neuroendocrine tumors in Norway and Sweden. World J Clin Cases 2020; 8(20): 4793-4806 [PMID: 33195647 DOI: 10.12998/wjcc.v8.i20.4793] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i20/4793.htm |
| Number | Citing Articles |
| 1 |
Ioana-Alexandra Soare, Oscar Leeuwenkamp, Louise Longworth. Estimation of Health-Related Utilities for 177Lu-DOTATATE in GEP-NET Patients Using Utilities Mapped from EORTC QLQ-C30 to EQ-5D-3L and QLU-C10D Utilities. PharmacoEconomics - Open 2021; 5(4): 715 doi: 10.1007/s41669-021-00280-9
|
| 2 |
Tony Cox, Matthew O’Connell, Oscar Leeuwenkamp, Stefan Palimaka, Nicholas Reed. Real-world comparison of healthcare resource utilization and costs of [177Lu]Lu-DOTA-TATE in patients with progressive neuroendocrine tumors in England: a matched cohort analysis using data from the hospital episode statistics dataset. Current Medical Research and Opinion 2022; 38(8): 1305 doi: 10.1080/03007995.2022.2065146
|
| 3 |
Dirk Mehrens, Kristina K.M. Kramer, Lena M. Unterrainer, Leonie Beyer, Peter Bartenstein, Matthias F. Froelich, Fabian Tollens, Jens Ricke, Johannes Rübenthaler, Nina-Sophie Schmidt-Hegemann, Annika Herlemann, Marcus Unterrainer, Wolfgang G. Kunz. Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer. Journal of the National Comprehensive Cancer Network 2023; 21(1): 43 doi: 10.6004/jnccn.2022.7070
|
| 4 |
Jessica Hooper, Nikie Jervis, Lucy Morgan, Vivienne Beckett, Philippa Hand, Kate Higgs, Alia Munir, Jenny Prinn, D Mark Pritchard, Debashis Sarker, Raj Srirajaskanthan, Catherine Bouvier Ellis. Neuroendocrine neoplasms: Consensus on a patient care pathway. Journal of Neuroendocrinology 2024; 36(4) doi: 10.1111/jne.13380
|